학술논문

Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study
Document Type
Article
Source
In: Dermatologic Therapy. (Dermatologic Therapy, June 2022, 35(6))
Subject
Language
English
ISSN
15298019
13960296